Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Singer

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
IRB|March 1, 1995
The incommensurability of research risks and benefits: practical help for research ethics committeesDouglas K Martin, Eric M Meslin, Nitsa Kohut, et al.
Humane Medicine|July 1, 1992
The University of Toronto Centre for BioethicsPeter A Singer, Carol Nash, Eric M Meslin, et al.
Plos Neglected Tropical Diseases|May 5, 2011
Franchising rabies vaccine delivery: the case of Indian immunologicalsHassan Masum, Hima Batavia, Natasha Bhogal, et al.
Nature Reviews. Genetics|October 1, 2008
Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)Béatrice Séguin, Billie-Jo Hardy, Peter A Singer, et al.
Regenerative Medicine|January 9, 2010
Cultivating regenerative medicine innovation in ChinaDominique S McMahon, Halla Thorsteinsdóttir, Peter A Singer, et al.
BMC Health Services Research|March 7, 2009
Priority setting: what constitutes success? A conceptual framework for successful priority settingShannon L Sibbald, Peter A Singer, Ross Upshur, et al.
Nature Biotechnology|August 11, 2010
Case study: India's billion dollar biotechJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Globalization and Health|April 22, 2011
Indian vaccine innovation: the case of Shantha BiotechnicsJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
BMC Public Health|December 7, 2007
How can developing countries harness biotechnology to improve health?Abdallah S Daar, Kathryn Berndtson, Deepa L Persad, et al.
Lancet (London, England)|March 22, 2003
Genomics--a global public good?Halla Thorsteinsdóttir, Abdallah S Daar, Richard D Smith, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
IRB|March 1, 1995
The incommensurability of research risks and benefits: practical help for research ethics committeesDouglas K Martin, Eric M Meslin, Nitsa Kohut, et al.
Humane Medicine|July 1, 1992
The University of Toronto Centre for BioethicsPeter A Singer, Carol Nash, Eric M Meslin, et al.
Plos Neglected Tropical Diseases|May 5, 2011
Franchising rabies vaccine delivery: the case of Indian immunologicalsHassan Masum, Hima Batavia, Natasha Bhogal, et al.
Nature Reviews. Genetics|October 1, 2008
Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)Béatrice Séguin, Billie-Jo Hardy, Peter A Singer, et al.
Regenerative Medicine|January 9, 2010
Cultivating regenerative medicine innovation in ChinaDominique S McMahon, Halla Thorsteinsdóttir, Peter A Singer, et al.
BMC Health Services Research|March 7, 2009
Priority setting: what constitutes success? A conceptual framework for successful priority settingShannon L Sibbald, Peter A Singer, Ross Upshur, et al.
Nature Biotechnology|August 11, 2010
Case study: India's billion dollar biotechJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Globalization and Health|April 22, 2011
Indian vaccine innovation: the case of Shantha BiotechnicsJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
BMC Public Health|December 7, 2007
How can developing countries harness biotechnology to improve health?Abdallah S Daar, Kathryn Berndtson, Deepa L Persad, et al.
Lancet (London, England)|March 22, 2003
Genomics--a global public good?Halla Thorsteinsdóttir, Abdallah S Daar, Richard D Smith, et al.
Pageof 16